U.S. pharmacy groups applaud journalists’ deep dive into the practices of pharmacy benefits managers that increase drug costs, reduce pharmacy sustainability.
The lawsuit alleges that companies benefitted from the opioid crisis ‘by negotiating favorable deals with opioid manufacturers and by not taking sufficient action to curb excessive opioid prescriptions.
A lack of procedural safeguards can lead to overly broad, disproportionate and unreasonable exercises of power in public decision making—including hospitals.
Attorney General Niki Sharma says the province is the first Canadian jurisdiction to sue makers of perfluoroalkyl and polyfluoroalkyl substances, known as PFAS chemicals.
